Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $680.9 million.

  • Roivant Sciences' Shares Outstanding (Diluted Average) fell 7.43% to $680.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $680.9 million, marking a year-over-year decrease of 7.43%. This contributed to the annual value of $725.4 million for FY2025, which is 12.71% down from last year.
  • Latest data reveals that Roivant Sciences reported Shares Outstanding (Diluted Average) of $680.9 million as of Q3 2025, which was up 0.10% from $680.3 million recorded in Q2 2025.
  • Roivant Sciences' Shares Outstanding (Diluted Average)'s 5-year high stood at $844.5 million during Q4 2023, with a 5-year trough of $649.9 million in Q2 2021.
  • Over the past 3 years, Roivant Sciences' median Shares Outstanding (Diluted Average) value was $735.6 million (recorded in 2024), while the average stood at $750.3 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first rose by 18.38% in 2023, then fell by 13.40% in 2024.
  • Roivant Sciences' Shares Outstanding (Diluted Average) (Quarterly) stood at $686.6 million in 2021, then increased by 3.89% to $713.3 million in 2022, then increased by 18.38% to $844.5 million in 2023, then fell by 13.40% to $731.3 million in 2024, then fell by 7.43% to $680.9 million in 2025.
  • Its last three reported values are $680.9 million in Q3 2025, $680.3 million for Q2 2025, and $725.4 million during Q1 2025.